News
![Photo: Bayer AG](https://pharmaphorum.com/wp-content/uploads/2017/09/Bayer_Cross_1.jpg)
MHRA, NHS England make available new prostate cancer treatme...
Jointly Bayer and Orion Corporation-developed NUBEQA (Darolutamide) + Androgen Deprivation Therapy (ADT) in combination with docetaxel is to be the first prostate cancer treatment to be mad